ANITA DESWAL to Natriuretic Peptide, Brain
This is a "connection" page, showing publications ANITA DESWAL has written about Natriuretic Peptide, Brain.
Connection Strength
1.682
-
NT-proBNP-guided and conventional therapies did not differ for readmission or mortality in acute decompensated HF. Ann Intern Med. 2018 08 21; 169(4):JC21.
Score: 0.522
-
BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study. Int J Cardiol. 2017 Apr 15; 233:61-66.
Score: 0.468
-
Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events: The ARIC Study. J Am Coll Cardiol. 2021 02 09; 77(5):559-571.
Score: 0.155
-
Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure). Circ Heart Fail. 2016 08; 9(8).
Score: 0.113
-
N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2016 Feb 16; 133(7):631-8.
Score: 0.109
-
Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA. 2013 Dec 18; 310(23):2533-43.
Score: 0.094
-
Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study. Clin Chem. 2013 Dec; 59(12):1802-10.
Score: 0.093
-
Reduction in BNP levels with treatment of decompensated heart failure and future clinical events. J Card Fail. 2009 May; 15(4):293-9.
Score: 0.067
-
Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction. Am Heart J. 2012 Nov; 164(5):763-770.e3.
Score: 0.022
-
Worsening renal function is not associated with response to treatment in acute heart failure. Int J Cardiol. 2013 Sep 01; 167(5):1912-7.
Score: 0.021
-
Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable heart failure. Vasc Health Risk Manag. 2010 Aug 09; 6:449-55.
Score: 0.019